Generally over the years, we've heard and reported on complaints about how new sites find it hard to rank above older sites. We also heard how old sites sometimes can't make changes and adapt as faster as new sites. Google's John Mueller said on Twitter that he hears the complaints on both ends.
from Search Engine Roundtable https://ift.tt/2SJhOoe
SEO, Search Engine Optimization, High Rank Search Engine registration,Internet marketing, Web marketing
5 Common WordPress Duplicate Content Issues & How to Fix Them via @sejournal, @rollerblader
Content duplication issues that can impact your site's search rankings are easy to detect and solve on WordPress. Here's how to fix them.
The post 5 Common WordPress Duplicate Content Issues & How to Fix Them appeared first on Search Engine Journal.
from Search Engine Journal https://ift.tt/3uJizvv
Schema.org Markup Validator Is Now Live
In December, Google told us they would move its structured data testing tool from Google's site to the Schema.org domain. Well, now, the Schema.org markup validator is now live, in beta at validator.schema.org.
from Search Engine Roundtable https://ift.tt/33BHchN
from Search Engine Roundtable https://ift.tt/33BHchN
Google 10 Local Pack - A Bug?
Google's local pack is typically three local listings, but here is an example of a local pack showing ten listings. This is probably a bug and was triggered by Ramesh Singh who shared this videocast of it on Twitter.
from Search Engine Roundtable https://ift.tt/33IVXzf
from Search Engine Roundtable https://ift.tt/33IVXzf
Google Ads: Cell Therapies and Gene Therapies Are Not Allowed
Google Ads clarified in its speculative and experimental medical treatment policy that cell therapies and gene therapies are therapies not allowed on the Google Ad network. This includes prohibiting stem cell therapy, cellular (non-stem) therapy, gene therapy and similar forms of regenerative medicine, platelet rich plasma and others.
from Search Engine Roundtable https://ift.tt/2RNOVXz
from Search Engine Roundtable https://ift.tt/2RNOVXz
Subscribe to:
Posts (Atom)